Cargando…
Pharmacotherapeutic targets in Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disorder which is characterized by an increasing impairment in normal memory and cognitive processes that significantly diminishes a person's daily functioning. Despite decades of research and advances in our understanding of dise...
Autores principales: | Biran, Yif'at, Masters, Colin L, Barnham, Kevin J, Bush, Ashley I, Adlard, Paul A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823037/ https://www.ncbi.nlm.nih.gov/pubmed/19040415 http://dx.doi.org/10.1111/j.1582-4934.2008.00595.x |
Ejemplares similares
-
Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
por: Adlard, Paul A., et al.
Publicado: (2018) -
β-amyloid in biological samples: not all Aβ detection methods are created equal
por: Adlard, Paul A., et al.
Publicado: (2014) -
Copper Modulation as a Therapy for Alzheimer's Disease?
por: Manso, Yasmina, et al.
Publicado: (2011) -
Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
por: Rojas, Milagros, et al.
Publicado: (2021) -
Metal Chaperones: A Holistic Approach to the Treatment of Alzheimer’s Disease
por: Adlard, Paul Anthony, et al.
Publicado: (2012)